Product Licensing
Bioscience company signs license agreement for small molecule oncology compounds
Published in Women's Health Weekly, September 8th, 2005
The Saskatchewan compounds appear to be highly potent chemopotentiators, drugs that enhance the activities of existing chemotherapeutic treatments. They are protected by three sets of intellectual property and have demonstrated activity in cancer, neurological and other degenerative diseases.
It is YM's intention to focus its own resources on the oncology applications and seek partners in order to advance these compounds in neurological...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
CD44 attenuated metastatic invasion during breast cancer progression - Hormones
Epithelial cell T-bet expression studied, role of female steroid hormones shown - Medical Devices
Preclinical studies of anti-adhesion thermal gel in gynecologic surgery underway - Osteoporosis
Companies announce agreement to develop new drug targeting osteoporosis - Antiproliferative Activity
Lamprey gonadotropin-releasing hormone III inhibited breast cancer cell growth - Bacterial Vaginosis
To understand BV, more research is needed on vaginal flora, related issues - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
